Healthcare (HC)

EDBI and Philips to accelerate healthcare innovation in Asia out of Singapore by coinvesting in high-potential digital health companies

News / By sinjie

Singapore – Singapore-based EDBI and Royal Philips (NYSE: PHG, AEX: PHIA) aim to accelerate their joint investment alliance and partner with more innovative companies in the digital health sector. This ambition is in line with Singapore’s latest focus to strengthen its position as a leading digital health hub.

Employee Benefits and Flex Wellness Marketplace CXA Group Announces USD25 Million Series B Investment to Expand To Over 10 Asian Markets Co-Led by B Capital Group and EDBI; Also Adds Philips, and RGA To List of High-Profile Investors

News / By sinjie

Eduardo Saverin to Join CXA’s Board With Lead Investment From B Capital Group, Backed by The Boston Consulting Group

CTI BioPharma Announces Progress Of Lead Programs And Strategic Objectives For 2017. Pacritinib Drug developed by S*BIO, EDBI Portfolio Company

News / By sinjie

SEATTLE, Jan. 9, 2017 /PRNewswire/ — CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced positive progress on its lead programs in addition to key business priorities for 2017.

Posts navigation

← Previous Page 1 … 4 5

Join our community!

Subscribe to our quarterly e-Newsletter, The Upside to find out what’s shaping the future industries of Singapore and the region.

Subscribe now

Careers
Terms of Use
Privacy

English

English
Chinese